The University of Chicago Header Logo

Should We Target Oligometastatic EGFR-Mutated NSCLC with Radiotherapy before Administering Targeted Systemic Therapy?

Should We Target Oligometastatic EGFR-Mutated NSCLC with Radiotherapy before Administering Targeted Systemic Therapy? J Natl Cancer Inst. 2022 Jan 30.

View in: PubMed